ArticleCancer medicine2022

Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.

Kathryn F Mileham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.